ctrl K

AI Score

Unlock

PMV Pharmaceuticals Inc. (PMVP)

AI Score

Unlock

0.99

-0.10 (-9.17%)

At close: Apr 01, 2025, 3:59 PM

1.02

3.92%

After-hours: Apr 01, 2025, 07:57 PM EDT

PMV Pharmaceuticals Income Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	1.26M	650K	1.28M	318K
Gross Profit	n/a	-1.26M	-650K	-1.28M	-318K
Operating Income	-85.45M	-80.13M	-77.04M	-58.29M	-34.94M
Interest Income	n/a	11.17M	3.63M	449K	651K
Pretax Income	-74.81M	-68.96M	-73.33M	-57.82M	-34.43M
Net Income	-58.71M	-68.96M	-73.32M	-57.85M	-34.44M
Selling & General & Admin	26.92M	24.25M	25.05M	21.8M	11.01M
Research & Development	58.53M	54.63M	51.99M	36.49M	23.93M
Other Expenses	n/a	n/a	87K	21K	-143K
Operating Expenses	85.45M	80.13M	77.04M	58.29M	34.94M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	80.13M	77.04M	58.29M	34.94M
Income Tax	-16.1M	2K	-9K	23K	6K
Shares Outstanding (Basic)	51.58M	48.01M	45.59M	45.14M	44.78M
Shares Outstanding (Diluted)	51.58M	48.01M	45.59M	45.14M	44.78M
EPS (Basic)	-1.14	-1.44	-1.61	-1.28	-2.4
EPS (Diluted)	n/a	n/a	n/a	n/a	n/a
EBITDA	-85.45M	-78.88M	-76.72M	-57.99M	-34.62M
Depreciation & Amortization	n/a	1.26M	650K	1.28M	318K